More about

University Of California San Francisco

News
November 26, 2018
2 min read
Save

Large study of black men with prostate cancer to look beyond genetics

Researchers at Keck School of Medicine of USC are leading a $26.5 million effort to conduct the first large-scale study of black men with prostate cancer.

News
November 12, 2018
2 min read
Save

Alcohol relapse score predicts early liver transplant eligibility

SAN FRANCISCO — A novel prognostic score using four objective pretransplant variables identified patients with alcoholic hepatitis who were candidates for early liver transplantation with a low risk for sustained alcohol use posttransplant, according to data presented at The Liver Meeting 2018.

News
October 14, 2018
1 min read
Save

Three researchers to be honored at San Antonio Breast Cancer Symposium

Three researchers to be honored at San Antonio Breast Cancer Symposium

Three highly regarded researchers will be honored at this year’s San Antonio Breast Cancer Symposium, scheduled for Dec. 4-8.

News
September 04, 2018
3 min read
Save

Infliximab biosimilar 'only moderately' less costly vs. biologic under Medicare Part D

Infliximab biosimilar 'only moderately' less costly vs. biologic under Medicare Part D

Under Medicare Part D drug benefits, the biosimilar infliximab-dyyb was only 18% less expensive than the infliximab reference product, exceeding $14,000 annually, according to a research letter published in JAMA.

News
September 02, 2018
2 min read
Save

Prostate Cancer Foundation presents Young Investigator Awards

The Prostate Cancer Foundation granted $6 million to 29 early-career scientists through its Young Investigator Awards program.

News
July 31, 2018
5 min read
Save

The liberating message of ‘Undetectable = Untransmittable’

The liberating message of ‘Undetectable = Untransmittable’

As ID professionals, we all are familiar with the concept of HIV treatment as prevention, or TasP. The science establishing TasP as an effective medical and public health strategy was established by HPTN 052, a randomized clinical trial involving 1,763 serodiscordant couples from nine different countries, which showed a 93% reduction in transmission risk in couples in which the infected partner was assigned to early ART. The implications of this finding were so significant that in 2011, Science highlighted the study as its “Breakthrough of the Year.” Collectively, results from HPTN 052 and several other landmark studies have validated that people living with HIV who have maximally suppressed virus on ART do not sexually transmit HIV to their partners. But surprisingly, this information has not been conveyed to the affected community in a meaningful way that would allow them to share its benefits.

News
July 28, 2018
2 min read
Save

American Society for Radiation Oncology members receive fellow designation

American Society for Radiation Oncology designated 35 members as ASTRO fellows.

News
July 24, 2018
2 min read
Save

Excessive napping indicates elevated dementia risk in older men

Older men who napped for 120 minutes or more per day were significantly more likely to develop dementia than those who napped for shorter durations, according to a presentation at the Alzheimer’s Association International Conference.

News
June 14, 2018
3 min read
Save

Studies review effect of overlapping spine surgery on outcomes

Studies review effect of overlapping spine surgery on outcomes

Spine and orthopedic surgery that is concurrent or overlapping is a hot topic that has led hospitals and investigators to examine this practice at their institutions. Two retrospective reviews published in the Journal of Neurosurgery showed the effect on outcomes after neurosurgery performed when two procedures were overlapping, or surgical steps were performed concurrently in different cases at any time during surgery.

News
May 18, 2018
1 min read
Save

AGA working group to address myths about IBD, pregnancy

AGA working group to address myths about IBD, pregnancy

To better guide women with inflammatory bowel disease throughout all stages of family planning, the American Gastroenterological Association is partnering with pharmaceutical company UCB, the Crohn’s & Colitis Foundation and the Society for Maternal-Fetal Medicine to create a working group to address some of the myths surrounding pregnancy and inflammatory bowel disease.

View more